Sara Heebøll

1.5k total citations
32 papers, 1.1k citations indexed

About

Sara Heebøll is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Sara Heebøll has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Physiology. Recurrent topics in Sara Heebøll's work include Liver Disease Diagnosis and Treatment (23 papers), Diet, Metabolism, and Disease (11 papers) and Diet and metabolism studies (5 papers). Sara Heebøll is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Diet, Metabolism, and Disease (11 papers) and Diet and metabolism studies (5 papers). Sara Heebøll collaborates with scholars based in Denmark, United States and Australia. Sara Heebøll's co-authors include Henning Grønbæk, Karen Louise Thomsen, Michael Borre, Stephen Hamilton‐Dutoit, Steen B. Pedersen, Filip K. Knop, Peter Lykke Eriksen, Kristoffer Rigbolt, Sanne Skovgård Veidal and Malte P. Suppli and has published in prestigious journals such as PLoS ONE, Diabetes and The Lancet Oncology.

In The Last Decade

Sara Heebøll

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Heebøll Denmark 14 575 365 247 203 194 32 1.1k
Dae Ho Lee South Korea 19 345 0.6× 296 0.8× 253 1.0× 109 0.5× 142 0.7× 44 908
M. Krausch Germany 15 799 1.4× 371 1.0× 458 1.9× 60 0.3× 258 1.3× 34 1.4k
Andria D’Orazio Italy 21 297 0.5× 452 1.2× 170 0.7× 212 1.0× 189 1.0× 30 1.6k
Kathrin Heinrich Germany 14 146 0.3× 385 1.1× 360 1.5× 228 1.1× 107 0.6× 69 1.4k
Charles‐Henry Gattolliat France 11 413 0.7× 429 1.2× 115 0.5× 190 0.9× 125 0.6× 12 881
Keizo Kagawa Japan 20 360 0.6× 300 0.8× 57 0.2× 140 0.7× 189 1.0× 70 1.1k
Mercedes Vázquez–Chantada United Kingdom 14 292 0.5× 770 2.1× 105 0.4× 180 0.9× 78 0.4× 28 1.1k
Rong Bu Saudi Arabia 26 170 0.3× 718 2.0× 195 0.8× 371 1.8× 50 0.3× 61 1.5k
Shuguang Zhu China 17 118 0.2× 493 1.4× 34 0.1× 240 1.2× 112 0.6× 48 1.1k
Morgane Baron France 9 484 0.8× 422 1.2× 171 0.7× 93 0.5× 123 0.6× 16 986

Countries citing papers authored by Sara Heebøll

Since Specialization
Citations

This map shows the geographic impact of Sara Heebøll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Heebøll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Heebøll more than expected).

Fields of papers citing papers by Sara Heebøll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Heebøll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Heebøll. The network helps show where Sara Heebøll may publish in the future.

Co-authorship network of co-authors of Sara Heebøll

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Heebøll. A scholar is included among the top collaborators of Sara Heebøll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Heebøll. Sara Heebøll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heebøll, Sara, Esben Søndergaard, Steffen Ringgaard, et al.. (2024). Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis. Journal of Lipid Research. 65(7). 100580–100580. 1 indexed citations
2.
Heebøll, Sara, Marie Winther‐Sørensen, Sasha A. S. Kjeldsen, et al.. (2024). Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms. Metabolism. 156. 155915–155915. 7 indexed citations
3.
Heebøll, Sara, Gregers Wegener, Henning Grønbæk, & Søren Nielsen. (2024). Comparable glucagon-stimulated amino acid suppression in individuals with and without hepatic steatosis or steatohepatitis. American Journal of Physiology-Endocrinology and Metabolism. 327(6). E679–E685. 2 indexed citations
4.
Heebøll, Sara, Kristian Løkke Funck, Esben Søndergaard, et al.. (2023). Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease. Atherosclerosis. 372. 10–18. 8 indexed citations
5.
Hansen, Henrik H., Denise Oró, Simon S. Evers, et al.. (2020). Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. BMC Gastroenterology. 20(1). 73 indexed citations
6.
Sundelin, Elias, Lars Christian Gormsen, Sara Heebøll, et al.. (2019). Hepatic exposure of metformin in patients with non‐alcoholic fatty liver disease. British Journal of Clinical Pharmacology. 85(8). 1761–1770. 16 indexed citations
7.
Eriksen, Peter Lykke, Hendrik Vilstrup, Kristoffer Rigbolt, et al.. (2019). Non‐alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion. Liver International. 39(11). 2094–2101. 53 indexed citations
8.
Thomsen, Karen Louise, Yong Oock Kim, Sara Heebøll, et al.. (2018). Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease. PLoS ONE. 13(3). e0192728–e0192728. 8 indexed citations
9.
Heebøll, Sara, Karen Louise Thomsen, Kasper Jarlhelt Andersen, et al.. (2018). Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis. World Journal of Hepatology. 10(1). 8–21. 12 indexed citations
10.
Suppli, Malte P., Kristoffer Rigbolt, Sanne Skovgård Veidal, et al.. (2018). Clinical Features and Hepatic Molecular Characteristics in NAFLD and NASH Patients Compared to Normal Weight Healthy Individuals. Diabetes. 67(Supplement_1). 1 indexed citations
11.
Chiara, Francesco De, Sara Heebøll, Giusi Marrone, et al.. (2018). Urea cycle dysregulation in non-alcoholic fatty liver disease. Journal of Hepatology. 69(4). 905–915. 138 indexed citations
12.
Eriksen, Peter Lykke, Karen Louise Thomsen, Tea Lund Laursen, et al.. (2017). Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD. Current Hepatology Reports. 16(4). 308–316. 1 indexed citations
13.
Heebøll, Sara, Stephen Hamilton‐Dutoit, Hans Stødkilde‐Jørgensen, et al.. (2016). Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology. 51(4). 456–464. 126 indexed citations
14.
Heebøll, Sara, Mikael Kjær Poulsen, Marie Juul Ørnstrup, et al.. (2016). Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls. International Journal of Obesity. 41(2). 262–267. 28 indexed citations
15.
Heebøll, Sara, Karen Louise Thomsen, Andrew D. Clouston, et al.. (2015). Effect of resveratrol on experimental non-alcoholic steatohepatitis. Pharmacological Research. 95-96. 34–41. 42 indexed citations
16.
Heebøll, Sara. (2014). Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. World Journal of Hepatology. 6(4). 188–188. 52 indexed citations
17.
Heebøll, Sara, Gerda Elisabeth Villadsen, Niels Kristian Aagaard, et al.. (2013). Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience. Scandinavian Journal of Gastroenterology. 48(8). 969–973. 7 indexed citations
18.
Sørensen, Karina D., Peter J. Wild, Ashkan Mortezavi, et al.. (2009). Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 15(4). 1400–1410. 25 indexed citations
19.
Heebøll, Sara, Michael Borre, Peter D. Ottosen, et al.. (2009). Snail1 is over‐expressed in prostate cancer. Apmis. 117(3). 196–204. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dae Ho Lee Breakdown of academic impact, for papers by M. Krausch Breakdown of academic impact, for papers by Andria D’Orazio Breakdown of academic impact, for papers by Kathrin Heinrich Breakdown of academic impact, for papers by Charles‐Henry Gattolliat Breakdown of academic impact, for papers by Keizo Kagawa Breakdown of academic impact, for papers by Mercedes Vázquez–Chantada Breakdown of academic impact, for papers by Rong Bu Breakdown of academic impact, for papers by Shuguang Zhu Breakdown of academic impact, for papers by Morgane Baron
Rankless by CCL
2026